Line1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk

Epigenetics

Volumn 10, Issue 4, 2015, Pages 282-292

  Karami, Sara ^a   Andreotti, Gabriella ^a   Liao, Linda M ^a   Pfeiffer, Ruth M ^a   Weinstein, Stephanie J ^a   Purdue, Mark P ^a   Hofmann, Jonathan N ^a   Albanes, Demetrius ^a   Mannisto, Satu ^b   Moore, Lee E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

ATBC; Cohort; Global methylation; Nested case contro; PLCO; Pre diagnostic blood DNA; Renal cell carcinoma; Smoking interaction

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER RISK; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOUBLE BLIND PROCEDURE; FEMALE; GENDER; GENE; HUMAN; ICD-O-2; KIDNEY CARCINOMA; LONG INTERSPERSED NUCLEOTIDE ELEMENT GENE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PYROSEQUENCING; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SMOKING; CARCINOMA, RENAL CELL; FINLAND; GENETICS; KIDNEY NEOPLASMS; LEUKOCYTE; LONG INTERSPERSED REPEAT; METABOLISM; PATHOLOGY;

AGED; CARCINOMA, RENAL CELL; DNA METHYLATION; FEMALE; FINLAND; HUMANS; KIDNEY NEOPLASMS; LEUKOCYTES; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; SMOKING;

EID: 84927754277     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.1080/15592294.2015.1006505     Document Type: Article

References (22)

1. Sproul D, Meehan RR. Genomic insights into cancerassociated aberrant CpG island hypermethylation. Brief Funct Genomics 2013;12(3):174-90; PMID:23341493; http://dx.doi.org/10.1093/bfgp/els063
2. Brennan K, Flanagan JM. Is there a link between genome-wide hypomethylation in blood and cancer risk? Cancer Prev Res (Phila) 2012;5(12):1345-57; PMID:23135621; http://dx.doi.org/10.1158/1940-6207.CAPR-12-0316
3. Mirabello L, Savage SA, Korde L, Gadalla SM, Greene MH. LINE-1 methylation is inherited in familial testicular cancer kindreds. BMC Med Genet 2010;11:77; PMID:20478068; http://dx.doi.org/10.1186/1471-2350-11-77
4. Wu HC, Delgado-Cruzata L, Flom JD, Perrin M, Liao Y, Ferris JS, Santella RM, Terry MB. Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the BCFR. Carcinogenesis 2012;33:1946-52; PMID:22678115; http://dx.doi.org/10.1093/carcin/bgs201
5. Woo HD, Kim J. Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis. PLoS One 2012;7(4):e34615; PMID:22509334; http://dx.doi.org/10.1371/journal.pone.0034615
6. Andreotti G, Karami S, Pfeiffer RM, Hurwitz L, Liao LM, Weinstein SJ, Albanes D, Virtamo J, Silverman DT, Rothman N, Moore LE. LINE1 methylation levels associated with increased bladder cancer risk in prediagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants. Epigenetics 2014;9(3):404-15; PMID:24316677; http://dx.doi.org/10.4161/epi.27386
7. Liao LM, Brennan P, van Bemmel D, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, et al. LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancer. PLoS One 2011;6(11):e27361; PMID:22076155; http://dx.doi.org/10.1371/journal.pone.0027361
8. Hayes RB, Sigurdson A, Moore L, Peters U, Huang WY, Pinsky P, Reding D, Gelmann EP, Rothman N, Pfeiffer RM, Hoover RN, Berg CD; PLCO Trial Team. Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res 2005;592:147-54; PMID:16054167; http://dx.doi.org/10.1016/j.mrfmmm.2005.06.013
9. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, et al. Alpha-Tocopherol and b-carotene supplements and lung cancer incidence in the a-tocopherol, b-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70; PMID:8901854; http://dx.doi.org/10.1093/jnci/88.21.1560
10. Nelson HH, Marsit CJ, Kelsey KT. Global methylation in exposure biology and translational medical science. Environ Health Perspect 2011;119:1528-33; PMID:21669556; http://dx.doi.org/10.1289/ehp.1103423
11. Yang AS, Estécio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004;32:e38; PMID:14973332; http://dx.doi.org/10.1093/nar/gnh032
12. Royo JL, Hidalgo M, Ruiz A. Pyrosequencing protocol using a universal biotinylated primer for mutation detection and SNP genotyping. Nat Protoc 2007;2:1734-9; PMID:17641638; http://dx.doi.org/10.1038/nprot.2007.244
13. Brakensiek K, Wingen LU, Länger F, Kreipe H, Lehmann U. Quantitative high-resolution CpG island mapping with Pyrosequencing reveals disease-specific methylation patterns of the CDKN2B gene in myelodysplastic syndrome and myeloid leukemia. Clin Chem 2007;53(1):17-23; PMID:17095538; http://dx.doi.org/10.1373/clinchem.2007.072629
14. England R, Pettersson M. Pyro Q-CpGTM: Quantitative analysis of methylation in multiple CpG sites by pyrosequencing. Nature Methods 2005;2:1-2; http://dx.doi.org/10.1038/nmeth800
15. Gao Y, Baccarelli A, Shu XO, Ji BT, Yu K, Tarantini L, Yang G, Li HL, Hou L, Rothman N, et al. Blood leukocyte Alu and LINE-1 methylation and gastric cancer risk in the Shanghai Women’s Health Study. Br J Cancer 2012;106:585-91; PMID:22173668; http://dx.doi.org/10.1038/bjc.2011.562
16. Wu HC, Wang Q, Yang HI, Tsai WY, Chen CJ, Santella RM. Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study. Carcinogenesis 2012;33:1340-5; PMID:22581841; http://dx.doi.org/10.1093/carcin/bgs160
17. Brennan K, Garcia-Closas M, Orr N, Fletcher O, Jones M, Ashworth A, Swerdlow A, Thorne H, K ConFab Investigators, Riboli E, Vineis P, et al. Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. Cancer Res 2012;72(9):2304-13; PMID: 22374981; http://dx.doi.org/10.1158/0008-5472.CAN-11-3157
18. Zhu ZZ, Sparrow D, Hou L, Tarantini L, Bollati V, Litonjua AA, Zanobetti A, Vokonas P, Wright RO, Baccarelli A, et al. Repetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence, and mortality in elderly individuals: the Normative Aging Study. Cancer Causes Control 2011;22:437-47; PMID:21188491; http://dx.doi.org/10.1007/s10552-010-9715-2
19. Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, García-Closas R, Chanock S, Tardón A, Serra C, et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the SpanishBladder Cancer Study: a case-control study. Lancet Oncol 2008;9:359-66; PMID:18339581; http://dx.doi.org/10.1016/S1470-2045(08)70038-X
20. Cash HL, Tao L, Yuan JM, Marsit CJ, Houseman EA, Xiang YB, Gao YT, Nelson HH, Kelsey KT. LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese. Int J Cancer 2012;130:1151-9; PMID:21445976; http://dx.doi.org/10.1002/ijc.26098
21. Furniss CS, Marsit CJ, Houseman EA, Eddy K, Kelsey KT. Line region hypomethylation is associated with lifestyle and differs by human papillomavirus status in head and neck squamous cell carcinomas.Cancer Epidemiol Biomarkers Prev 2008;17(4):966-71; PMID:18398038; http://dx.doi.org/10.1158/1055-9965.EPI-07-2775
22. Ludgate JL, Le Mée G, Fukuzawa R, Rodger EJ, Weeks RJ, Reeve AE, Morison IM. Global demethylation in loss of imprinting subtype of Wilms tumor. Genes Chromosomes Cancer 2013;52(2):174-84; PMID:23074036; http://dx.doi.org/10.1002/gcc.22017